Cargando…
A genomic biomarker-based model for cancer risk stratification of non-dysplastic Barrett’s esophagus patients after extended follow up; results from Dutch surveillance cohorts.
Barrett’s esophagus is the only known mucosal precursor for the highly malignant esophageal adenocarcinoma. Malignant degeneration of non-dysplastic Barrett’s esophagus occurs in < 0.6% per year in Dutch surveillance cohorts. Therefore, it has been proposed to increase the surveillance intervals...
Autores principales: | Hoefnagel, S. J. M., Mostafavi, N., Timmer, M. R., Lau, C. T., Meijer, S. L., Wang, K. K., Krishnadath, K. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153893/ https://www.ncbi.nlm.nih.gov/pubmed/32282835 http://dx.doi.org/10.1371/journal.pone.0231419 |
Ejemplares similares
-
Detection of circulating BMP5 as a risk factor for Barrett’s esophagus
por: Correia, Ana C. P., et al.
Publicado: (2020) -
The role of ablation in the treatment of dysplastic Barrett’s esophagus
por: Sullivan, Rebecca, et al.
Publicado: (2021) -
State-of-the-art management of dysplastic Barrett's esophagus
por: Vantanasiri, Kornpong, et al.
Publicado: (2022) -
An Urban Center Experience Exploring Barriers to Adherence to Endoscopic Surveillance for Non-Dysplastic Barrett’s Esophagus
por: Isseh, Mahmoud, et al.
Publicado: (2021) -
Surveillance in Barrett Esophagus
por: Gindea, C, et al.
Publicado: (2014)